Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Oncolytics Biotech, Inc (NASDAQ: ONCY) was $0.43 for the day, down -4.00% from the previous closing price of $0.44. In other words, the price has decreased by -$4.00 from its previous closing price. On the day, 0.77 million shares were traded.
Ratios:
Our analysis of ONCY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.21 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 06, 2022, initiated with a Buy rating and assigned the stock a target price of $3.
Stock Price History:
Over the past 52 weeks, ONCY has reached a high of $1.53, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -13.40%, while the 200-Day Moving Average is calculated to be -46.65%.
Shares Statistics:
A total of 86.42M shares are outstanding, with a floating share count of 85.97M. Insiders hold about 3.21% of the company’s shares, while institutions hold 10.75% stake in the company.
Earnings Estimates
Currently, 3.0 analysts are dedicated to thoroughly evaluating and rating the performance of Oncolytics Biotech, Inc (ONCY) in the stock market.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.31 and -$0.39 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.38, with 3.0 analysts recommending between -$0.33 and -$0.42.
